ALTERATIONS DANS L'EXPRESSION DU GENE ERG SPECIFIQUES DU CANCER DE LA PROSTATE, ET PROCEDES DE DETECTION ET DE TRAITEMENT EN FONCTION DE CES ALTERATIONS
Alterations in ERG gene expression can be observed in patients with prostatecancer. Specific ERG isoforms areassociated with, or involved in, prostate cancer. Compositions comprisingthese isoforms provide therapeutic benefit and can beused in methods of detecting, diagnosing, prognosing, and treating prostatecancer. These compositions provide biomarkers fordetecting the expression of combinations of the PSA/KLK3, PMEPA1, NKX3.1,ODC1, AMD1, and ERG genes.